Clinical Trials on Risk Factors for Respiratory and Cardiovascular Disease in New Zealand
Total 14677 results
-
University of RochesterCompletedLow Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk FactorsUnited States
-
Northwell HealthActive, not recruitingCardiovascular Risk FactorUnited States
-
Heart Force Medical Inc.Completed
-
University Hospital, EssenCompletedCardiovascular Diseases | Cardiovascular Risk Factor | SARSGermany
-
VA Office of Research and DevelopmentCompletedCardiovascular Diseases | Cigarette Use | Alcohol Use Above Recommended Limits | Cardiovascular Risk Factors (e.g., Hypertension)United States
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI); University of Texas; Clinical...Active, not recruiting
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteCompletedCoronary Disease | Cardiac Arrest | Cardiovascular Risk FactorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHigh Risk for Postoperative Cardiovascular EventsUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingObstetric Labor Complications | Cardiovascular Risk Factor | Cardiovascular Diseases in PregnancyUnited States
-
University Hospital, EssenFederal Ministry of Education and Reserach (BMBF)CompletedDetection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...Germany
-
Pharmosa Biopharm Inc.Novotech (New Zealand) LimitedNot yet recruitingPulmonary Arterial HypertensionNew Zealand
-
Tulane UniversityCompletedDepression | Cardiovascular Diseases | Hypertension | Obesity | Diabetes | Cancer | Nutrition Disorders | Physical Activity | Cardiovascular Risk FactorUnited States
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Ceryx Medical AustraliaAvaniaNot yet recruitingHeart Failure With Reduced Ejection FractionNew Zealand
-
Crux BiomedicalCompletedPulmonary EmbolismNew Zealand, Australia
-
Ochsner Health SystemBracco CorporateCompletedMyocardial Infarction | Coronary Artery Disease | Cardiac Risk Factors | Normal Healthy Volunteers Without Chronic Medical ConditionsUnited States
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
LIB Therapeutics LLCMedpace, Inc.Active, not recruitingCardiovascular Diseases | Hypercholesterolemia | Cardiovascular Risk Factor | Cardiovascular StrokeUnited States, Israel, India
-
Restorbio Inc.CompletedRespiratory Tract InfectionsNew Zealand
-
State University of New York at BuffaloAmerican Egg BoardCompletedObesity | Metabolic Syndrome | Cardiovascular Risk Factor | Food Allergy | Growth & Development | Cognitive Developmental DelayUnited States
-
John HaleRecruitingLower Respiratory Tract Infection | Upper Respiratory Tract InfectionNew Zealand
-
GlaxoSmithKlineCompleted
-
NYU Langone HealthCompletedHypertension | Stress Disorders, Post-Traumatic | Insulin Resistance | Asthma | Cardiovascular Risk Factor | Exposure to Toxic DustUnited States
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
University of OtagoCompleted
-
Lumen BiomedicalCompletedFresh Soft Emboli or Thrombi in the Arteries.New Zealand
-
Middlemore Hospital, New ZealandUnknown
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Fisher and Paykel HealthcareTerminatedObesity Hypoventilation SyndromeNew Zealand
-
Fisher and Paykel HealthcareTerminatedSleep Disordered Breathing | Congestive Heart FailureNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
VaxartCompletedSeasonal Influenza BNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Arrowhead PharmaceuticalsCompleted
-
Shockwave Medical, Inc.Completed
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Fisher and Paykel HealthcareTerminatedSleep Apnea, Obstructive | Obesity Hypoventilation SyndromeNew Zealand
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Fisher and Paykel HealthcareTerminatedSleep-disordered Breathing | HypercapniaNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep ApneaNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand